BNET Industries
Market Cap:$3.0M
Last Fiscal Year Sales:$19.2M
- Public
- US
Dow Jones Description
Mfr, Developer & Marketer of Veterinary Diagnostics, Vaccines & Other Animal Health Related Products
President and CEO
Paul R. HaysNumber of Employees 100
Contact Information
12200 NW Ambassador Dr Ste 101
Kansas City, Missouri 64163
(858) 464-3500
Peer Companies
NAICS Code In-Vitro Diagnostic Substance Manufacturing: 325413
News & Analysis
Filter by
strategy and synbiotics corp. - All News and Analysis
Synbiotics Corp. receives USDA approval for room temperature storage of ICT GOLD HW diagnostic; new storage saves time, money and shelf space
- 1996-05-02
SAN DIEGO--BUSINESS WIRE--May 2, 1996--Synbiotics Corp. (NASDAQ:SBIO) Thursday announced that it has received USDA approval for room temperature storage of its leading diagnostic test, ICT GOLD HW, for canine heartworm diagnosis.The new approval gives Synbiotics the first heartworm diagnostic test that can be stored at room temperature without affecting the...
Synbiotics Corp. reports results for fiscal 1995; ICT GOLD HW diagnostic test drives revenue growth
- 1996-03-29
SAN DIEGO--BUSINESS WIRE--March 29, 1996--Synbiotics Corp. (NASDAQ:SBIO) Friday reported revenues of $14.1 million for the year ended Dec. 31, 1995 versus $12.1 million for the prior 12 month period, an increase of 17%.The company also reported net income of $501,000 or 9 cents per share for 1995, compared to a...
Synbiotics Corp. receives USDA license for ICT heartworm diagnostic test; accurate, fast, user-friendly test format
- 1995-03-22
SAN DIEGO--BUSINESS WIRE--March 22, 1995--Synbiotics Corp. (NASDAQ:SBIO) Wednesday announced that it has received a USDA license for its new state-of-the-art ICT canine heartworm diagnostic test.Synbiotics will immediately begin marketing its ICT heartworm test to the $16.5 million U.S. in-clinic stat canine heartworm diagnostic market.The Synbiotics test is a folding cardlike...
- 1
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Paul R. Hays | President and CEO |
| Keith A. Butler | Cfo |
| B. Kent Luther | Vice President, Sales & Marketing |
| Chinta Lamichhane | Vice President, R & D |
| Clifford Frank | Vice President, Strategic Projects |
| Michael Harrod | Director of Technical Resources |
| Christophe Calleja | Marketing Manager |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Donald E Phillips | Chairman of the Board of Directors |
| Christopher P. Hendy | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| Synbiotics Corporation | President and CEO | Current |
| Synbiotics Europe S.A.S. | President | Current |
| Synbiotics Corporation | Board of Directors | Former |
| Organization | Position | Status |
|---|---|---|
| Synbiotics Corporation | Cfo | Current |
| Synbiotics Corporation | Vice President | Current |
| Synbiotics Corporation | Board of Directors | Former |
| Organization | Position | Status |
|---|---|---|
| Synbiotics Corporation | Vice President, Sales & Marketing | Current |
| Organization | Position | Status |
|---|---|---|
| Synbiotics Corporation | Vice President, R & D | Current |
| Organization | Position | Status |
|---|---|---|
| Synbiotics Corporation | Vice President, Strategic Projects | Current |
| Organization | Position | Status |
|---|---|---|
| Synbiotics Corporation | Director of Technical Resources | Current |
| Organization | Position | Status |
|---|---|---|
| Synbiotics Corporation | Marketing Manager | Current |
| Organization | Position | Status |
|---|---|---|
| Finds Ammonia | Current | |
| Synbiotics Corporation | Chairman of the Board of Directors | Current |
| Mississippi.Com | President | Former |
| Organization | Position | Status |
|---|---|---|
| Redwood Holdings, Inc. | Current | |
| Schonstedt Instrument Company | Board of Directors | Current |
| Synbiotics Corporation | Board of Directors | Current |
| Marine Midland Bank | Former | |
| Xavier University | B.S. Degree In Business Administration | Former |
Industry Transcripts by Seeking Alpha
-
Peregrine Pharmaceuticals Inc. F2Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Dec 10, 2009about PPHM
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
Glass Door
Pharma Industry Companies
| Company | Employer Rating |
| Johnson & Johnson |  |
| Merck | |
| Pfizer | |
| Novartis |  |
| Abbott Labs | |
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Why J&J's Stelara Launch Should Target Dermatologists First 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes
- More Tysabri Problems; Time for a Biogen-Idec Credibility Check 3 votes
Presented by American Express